Firefly Neuroscience (AIFF) Net Equity Issued and Repurchased (2021 - 2023)
Firefly Neuroscience (AIFF) posted Net Equity Issued and Repurchased of $290842.0 for Q3 2023, up 10239.21% on a QoQ basis from $2813.0 in Q2 2023.
Powered by 
Analysis
Firefly Neuroscience (AIFF) Net Equity Issued and Repurchased (2021 - 2023) Analysis & Trends
Firefly Neuroscience has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $290842.0 in Q3 2023.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $290842.0 in Q3 2023; TTM through Jun 2024 was $290842.0, a 416.91% increase from a year earlier, with the FY2023 full-year figure at $347108.0, down 81.61% from the prior year.
- Net Equity Issued and Repurchased was $290842.0 for Q3 2023 at Firefly Neuroscience, up from $2813.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $10.0 million in Q4 2021, with the low at -$1445.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | - |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 400,000.00 |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | - |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | - |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 290,842.00 |
| Jun 30, 2023 | 2,813.00 |
| Mar 31, 2023 | 53,453.00 |
| Dec 31, 2021 | 10.00 Mn |
| Sep 30, 2021 | 2.80 Mn |
| Jun 30, 2021 | -1,445.00 |
| Mar 31, 2021 | 495,999.00 |